UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 17,
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Boundless Bio Charts.
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Boundless Bio Charts.

News Audentes Therapeutics, Inc.

Boundless Bio to Participate in the Piper Sandler Healthcare Conference
Montag 25 November 2024 (2 Tage vor) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)
Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Donnerstag 7 November 2024 (3 Wochen vor) • GlobeNewswire Inc.
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
Dienstag 5 November 2024 (3 Wochen vor) • GlobeNewswire Inc.
Form 8-K - Current report
Dienstag 15 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)
Boundless Bio Announces Departure of Chief Financial Officer
Montag 14 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
Mittwoch 11 September 2024 (3 Monate vor) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 21 August 2024 (3 Monate vor) • Edgar (US Regulatory)
Form 8-K - Current report
Dienstag 20 August 2024 (3 Monate vor) • Edgar (US Regulatory)
Form 8-K - Current report
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Audentes Therapeutics, Inc. News-Artikel

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€